ACST - Acasti Pharma Inc. (ACST) CEO Jan D'Alvise on Q3 2021 Results - Earnings Call Transcript
Acasti Pharma Inc. (ACST) Q3 2021 Earnings Conference Call February 14, 2022 1:00 PM ET Company Participants David Waldman - Investor Relations Jan D’Alvise - President and Chief Executive Officer Brian Ford - Chief Financial Officer George Kottayil - Chief Operating Officer US Conference Call Participants Sahil Kazmi - B. Riley Securities Alexandra Heller - Oppenheimer Presentation Operator Good day, ladies and gentlemen, and welcome to the Acasti Pharma Third Quarter Fiscal 2022, Business Update Conference Call. At this time, all participants have been placed on a listen-only mode and the floor will be open for questions and comments after the presentation. It is now my pleasure to turn the floor over to your host, David Waldman with Investor Relations. Sir, the floor is yours. David Waldman Thank you, Holly. And good afternoon, everyone. I would like to welcome you to Acasti Pharma's Fiscal 2022, Third Quarter Conference Call. On
For further details see:
Acasti Pharma Inc. (ACST) CEO Jan D'Alvise on Q3 2021 Results - Earnings Call Transcript